The study was conducted by researchers in Japan. The prospective study included 2,069 patients, with 1,582 patients receiving hospital-based palliative care and 487 patients receiving home-based palliative care.
The results of the study showed the survival of patients who died at home was significantly longer than the survival of patients who died in a hospital among the days’ prognosis group — with an estimated median survival time of 13 days compared to nine days — and in the weeks’ prognosis group — with a survival time of 36 days compared to 29 days.
Lead author of the study, Jun Hamano, MD, says the findings could impact patient choice surrounding hospice care.
“The cancer patient and family tend to be concerned that the quality of medical treatment provided at home will be inferior to that given in a hospital and that survival might be shortened; however, our finding…could suggest that the patient and family can choose the place of death in terms of their preference and values,” said Dr. Hamano. “Patients, families and clinicians should be reassured that good home hospice care does not shorten patient life, and even may achieve longer survival.”
More articles on hospice care:
Another side effect of EHRs that don’t talk: Conflicting end-of-life directives
Joint Commission creates palliative care certification for home health and hospice facilities
5 healthcare practices that are failing seniors
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.